Results 11 to 20 of about 2,931,663 (352)
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
Clinical Epidemiology, 2019 Aurore Bergamasco,1 Nadine Hartmann,2 Laura Wallace,3 Patrice Verpillat41YolaRx Consultants, Paris, France; 2Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; 3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CO, USA ...
Bergamasco A +3 more
doaj +3 more sources
Renal involvement in systemic sclerosis
Autoimmunity Reviews, 2023 Systemic sclerosis is a rare autoimmune vasculopathy associated with dysregulated innate and adaptive immunity that leads to generalized systemic fibrosis.
Valérie Olivier +2 more
exaly +2 more sources
The burden of systemic sclerosis in Switzerland – the Swiss systemic sclerosis EUSTAR cohort [PDF]
Swiss Medical Weekly, 2021 OBJECTIVES Characteristics of Swiss patients with systemic sclerosis have not been described so far. The aim of the current study was to identify unmet needs in comparison with other European countries that could inform specific interventions
Jasmin Hernández +23 more
doaj +3 more sources
Indian Journal of Dental Research, 2007 Systemic sclerosis (scleroderma) is a rare generalized disorder of connective tissue origin. This condition is predominantly a clinical diagnosis, based on the clinical signs and symptoms.
Ahathya R, Deepalakshmi D, Emmadi Pamela
doaj +3 more sources
Systemic sclerosis – diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1: diagnosis and monitoring [PDF]
Przegląd Dermatologiczny, 2017 Systemic sclerosis is an immune-mediated disease characterized by a chronic and progressive course. It often leads to multiorgan failure and patient disability, and contributes to significant reduction in the quality of life.
Dorota Krasowska +10 more
doaj +2 more sources
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
American Journal of Respiratory and Critical Care Medicine, 2019 RATIONALE Interstitial lung disease (ILD) represents a major challenge in systemic sclerosis (SSc), but there are no precise, population-based data on its overall impact, limiting opportunities for screening and management strategies.
Anna-Maria Hoffmann-Vold +2 more
exaly +2 more sources
Animal models of systemic sclerosis: their utility and limitations
Open Access Rheumatology: Research and Reviews, 2014 Carol M Artlett Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA Abstract: Without doubt, animal models have provided significant insights into our understanding of the rheumatological diseases ...
Artlett CM
doaj +1 more source
Biologics: Targets & Therapy, 2008 Mathieu C Tamby1, Amélie Servettaz1, Nicolas Tamas1, Joseph Reinbolt2, Frédéric Caux3, Olivier Meyer4, Yannick Allanore5, André Kahan5, Loïc Guillevin6, Luc Mouthon1,61Paris-Descartes University ...
Mathieu C Tamby +5 more
doaj +1 more source
Scientific Reports, 2021 Our previous study demonstrated increased expression of Heat shock protein (Hsp) 90 in the skin of patients with systemic sclerosis (SSc). We aimed to evaluate plasma Hsp90 in SSc and characterize its association with SSc-related features. Ninety-two SSc
H. Štorkánová +11 more
semanticscholar +1 more source